Id |
Subject |
Object |
Predicate |
Lexical cue |
T90 |
0-130 |
Sentence |
denotes |
For patient #1 SARS‐CoV‐2 RT‐PCR Kit (altona Diagnostics) and for patients #2, #3 and #4 cobas® SARS‐CoV‐2 Test (Roche) were used. |
T91 |
131-180 |
Sentence |
denotes |
For patient #5, kit manufacturer remains unknown. |
T92 |
181-313 |
Sentence |
denotes |
Respective C t values are given in Table 1 where available. hMPV‐PCR was performed with NxTAG® Respiratory Pathogen Panel (Luminex). |
T93 |
314-406 |
Sentence |
denotes |
Aspergillus 28S rDNA‐Realtime PCR was performed as in‐house PCR test for screening purposes. |
T94 |
407-471 |
Sentence |
denotes |
Species identification was performed by artus® Aspergillus diff. |
T95 |
472-492 |
Sentence |
denotes |
RG PCR kit (Qiagen). |
T96 |
493-660 |
Sentence |
denotes |
For galactomannan testing from serum, bronchoalveolar lavage fluid (BALF) or tracheal aspirate (TA) Platelia Aspergillus antigen ELISA (Bio‐Rad Laboratories) was used. |
T97 |
661-765 |
Sentence |
denotes |
Antifungal susceptibility testing was performed using concentration gradient strips on RPMI agar plates. |
T98 |
766-928 |
Sentence |
denotes |
In brief, spore suspensions of the fungal isolates were adjusted to 106 CFU/mL and inoculated with MIC test strips for itraconazole and voriconazole (bioMérieux). |
T99 |
929-996 |
Sentence |
denotes |
MICs were determined visually after 48 hours of incubation at 35°C. |
T100 |
997-1094 |
Sentence |
denotes |
VIPcheck™ (Mediaproducts BV) was performed in patient #1 for early detection of azole resistance. |
T101 |
1095-1096 |
Sentence |
denotes |
6 |